Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshihisa Kitamura

Showing results (41-50 of 251) with videos related to

Pageof 26
Sort By:
Biological & Pharmaceutical Bulletin|January 8, 2011
Parkinsonian rotenone mouse model: reevaluation of long-term administration of rotenone in C57BL/6 miceMasatoshi Inden, Yoshihisa Kitamura, Mari Abe, et al.
Glia|July 15, 2010
The 6-hydroxydopamine-induced nigrostriatal neurodegeneration produces microglia-like NG2 glial cells in the rat substantia nigraYoshihisa Kitamura, Masatoshi Inden, Hideaki Minamino, et al.
Biological & Pharmaceutical Bulletin|September 15, 2012
Detoxification of 6-hydroxydopamine-induced dopaminergic neurodegeneration by 5,5-dimethyl-1-pyrroline N-oxide, a radical trapper, in hemiparkinsonian ratsMasatoshi Inden, Yoshihisa Kitamura, Kazuyuki Takata, et al.
Journal of Neuroscience Research|October 23, 2004
High mobility group box protein-1 inhibits microglial Abeta clearance and enhances Abeta neurotoxicityKazuyuki Takata, Yoshihisa Kitamura, Daiju Tsuchiya, et al.
Biological & Pharmaceutical Bulletin|June 4, 2008
Possible involvement of P2X7 receptor activation in microglial neuroprotection against focal cerebral ischemia in ratsDaijiro Yanagisawa, Yoshihisa Kitamura, Kazuyuki Takata, et al.
Acta Medica Okayama|October 23, 2013
Preparation of enteric-coated capsules of beclomethasone dipropionate for patients with intestinal graft-versus-host disease and a case studyKiminaka Murakawa, Tomoaki Sato, Yoshinobu Maeda, et al.
Biological & Pharmaceutical Bulletin|January 5, 2010
R-(-)-alpha-methylhistamine, a histamine H3 receptor agonist, induces endothelium-dependent vasodilation in rat mesenteric resistance arteriesPengyuan Sun, Xin Jin, Toshihiro Koyama, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 6, 2007
[Strategy to develop a new drug for treatment-resistant depression--role of electroconvulsive stimuli and BDNF]Bingjin Li, Katsuya Suemaru, Yoshihisa Kitamura, et al.
Journal of Clinical Pharmacy and Therapeutics|September 25, 2020
Investigation of the difficulties experienced by pharmacists in Japan when communicating with cancer patientsSachiyo Kameda, Yoshihisa Kitamura, Yasuyuki Masaoka, et al.
Acta Medica Okayama|May 3, 2022
Retrospective Cohort Study of Clinical Efficacy and Safety of Cefozopran for Treating Febrile Neutropenia during Chemotherapy in Patients with Lung CancerTsukasa Higashionna, Soichiro Ushio, Satoru Esumi, et al.
Pageof 26

Showing results (41-50 of 251) with videos related to

Sort By:
Pageof 26
Biological & Pharmaceutical Bulletin|January 8, 2011
Parkinsonian rotenone mouse model: reevaluation of long-term administration of rotenone in C57BL/6 miceMasatoshi Inden, Yoshihisa Kitamura, Mari Abe, et al.
Glia|July 15, 2010
The 6-hydroxydopamine-induced nigrostriatal neurodegeneration produces microglia-like NG2 glial cells in the rat substantia nigraYoshihisa Kitamura, Masatoshi Inden, Hideaki Minamino, et al.
Biological & Pharmaceutical Bulletin|September 15, 2012
Detoxification of 6-hydroxydopamine-induced dopaminergic neurodegeneration by 5,5-dimethyl-1-pyrroline N-oxide, a radical trapper, in hemiparkinsonian ratsMasatoshi Inden, Yoshihisa Kitamura, Kazuyuki Takata, et al.
Journal of Neuroscience Research|October 23, 2004
High mobility group box protein-1 inhibits microglial Abeta clearance and enhances Abeta neurotoxicityKazuyuki Takata, Yoshihisa Kitamura, Daiju Tsuchiya, et al.
Biological & Pharmaceutical Bulletin|June 4, 2008
Possible involvement of P2X7 receptor activation in microglial neuroprotection against focal cerebral ischemia in ratsDaijiro Yanagisawa, Yoshihisa Kitamura, Kazuyuki Takata, et al.
Acta Medica Okayama|October 23, 2013
Preparation of enteric-coated capsules of beclomethasone dipropionate for patients with intestinal graft-versus-host disease and a case studyKiminaka Murakawa, Tomoaki Sato, Yoshinobu Maeda, et al.
Biological & Pharmaceutical Bulletin|January 5, 2010
R-(-)-alpha-methylhistamine, a histamine H3 receptor agonist, induces endothelium-dependent vasodilation in rat mesenteric resistance arteriesPengyuan Sun, Xin Jin, Toshihiro Koyama, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 6, 2007
[Strategy to develop a new drug for treatment-resistant depression--role of electroconvulsive stimuli and BDNF]Bingjin Li, Katsuya Suemaru, Yoshihisa Kitamura, et al.
Journal of Clinical Pharmacy and Therapeutics|September 25, 2020
Investigation of the difficulties experienced by pharmacists in Japan when communicating with cancer patientsSachiyo Kameda, Yoshihisa Kitamura, Yasuyuki Masaoka, et al.
Acta Medica Okayama|May 3, 2022
Retrospective Cohort Study of Clinical Efficacy and Safety of Cefozopran for Treating Febrile Neutropenia during Chemotherapy in Patients with Lung CancerTsukasa Higashionna, Soichiro Ushio, Satoru Esumi, et al.
Pageof 26